Live feed
Filing
SC 13D/A
SC 13D/A0001104659-21-115514·POINT Biopharma Global Inc.
Schedule 13D ownership disclosure
POINT BIOPHARMA GLOBAL INC
Security class unavailable · CUSIP: 730541109
Event date: 2021-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,856,018
- Percent of class
- 9.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-115514
- Form type
- SC 13D/A
- Filer
- POINT Biopharma Global Inc.
- CIK
- CIK 1811764
- Filed
- Sep 14, 2021
- Reporting period
- Jun 30, 2021
- Description
- Schedule 13D beneficial ownership